{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anti-proliferative", "antioxidants", "apoptosis", "spiroxindoles", "synthesis"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32208781", "DateCompleted": {"Year": "2020", "Month": "12", "Day": "15"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "30"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1080/14756366.2020.1743281"], "Journal": {"ISSN": "1475-6374", "JournalIssue": {"Volume": "35", "Issue": "1", "PubDate": {"Year": "2020", "Month": "Dec"}}, "Title": "Journal of enzyme inhibition and medicinal chemistry", "ISOAbbreviation": "J Enzyme Inhib Med Chem"}, "ArticleTitle": "Antitumor properties of certain spirooxindoles towards hepatocellular carcinoma endowed with antioxidant activity.", "Pagination": {"StartPage": "831", "EndPage": "839", "MedlinePgn": "831-839"}, "Abstract": {"AbstractText": ["In the current medical era, spirooxindole motif stands out as a privileged heterospirocyclic scaffold that represents the core for a wide range of bioactive naturally isolated products (such as Strychnofoline and spirotryprostatins A and B) and synthetic compounds. Interestingly, no much attention has been paid to develop spirooxindole derivatives with dual antioxidant and anticancer activities. In this context, a series of spirooxindoles 6a-p was examined for their anticancer effect towards HepG2 hepatocellular carcinoma and PC-3 prostate cancer cell lines. Spirooxindole 6a was found to be an efficient anti-proliferative agent towards both HepG2 and PC-3 cells (IC50\u2009=\u20096.9 and 11.8\u2009\u00b5M, respectively). Afterwards, spirooxindole 6a was assessed for its apoptosis induction potential in HepG2 cells, where its pro-apoptotic impact was approved via the significant elevation in the Bax/Bcl-2 ratio and the expression levels of caspase-3."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}], "LastName": "Al-Rashood", "ForeName": "Sara T", "Initials": "ST"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry of Medicinal Plants, National Research Centre, Dokki, Egypt."}, {"Identifier": [], "Affiliation": "Biology Unit, Central Laboratory of the Pharmaceutical & Drug Industries Research Division, National Research Centre, Dokki, Egypt."}], "LastName": "Hamed", "ForeName": "Ahmed R", "Initials": "AR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt."}], "LastName": "Hassan", "ForeName": "Ghada S", "Initials": "GS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}], "LastName": "Alkahtani", "ForeName": "Hamad M", "Initials": "HM"}, {"Identifier": ["0000-0001-8711-3873"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}], "LastName": "Almehizia", "ForeName": "Abdulrahman A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}], "LastName": "Alharbi", "ForeName": "Amal", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia."}], "LastName": "Al-Sanea", "ForeName": "Mohammad M", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafr El-Sheikh, Egypt."}], "LastName": "Eldehna", "ForeName": "Wagdy M", "Initials": "WM"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Enzyme Inhib Med Chem", "NlmUniqueID": "101150203", "ISSNLinking": "1475-6366"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Biphenyl Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxindoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Picrates"}, {"RegistryNumber": "0", "NameOfSubstance": "Spiro Compounds"}, {"RegistryNumber": "DFD3H4VGDH", "NameOfSubstance": "1,1-diphenyl-2-picrylhydrazyl"}], "MeshHeadingList": [{"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Biphenyl Compounds"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Carcinoma, Hepatocellular"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Hep G2 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Liver Neoplasms"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Oxindoles"}, {"QualifierName": [], "DescriptorName": "PC-3 Cells"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Picrates"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Spiro Compounds"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}], "CoiStatement": "No potential conflict of interest was reported by the author(s)."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "(a) de Torre MP, Cavero RY, Calvo MI, Vizmanos JL, A simple and a reliable method to quantify antioxidant activity in\u00a0vivo. Antioxidants 2019;8:142.", "ArticleIdList": ["PMC6562907", "31121854"]}, {"Citation": "(b) Kundu T, Bhattacharjee B, Hazra S, et al. . Synthesis and biological assessment of pyrrolobenzoxazine scaffold as a potent antioxidant. J Med Chem 2019;62:6315\u201329.", "ArticleIdList": ["31246452"]}, {"Citation": "Habrant D, Poigny S, S\u00e9gur-Derai M, et al. . Evaluation of antioxidant properties of monoaromatic derivatives of pulvinic acids. J Med Chem 2009;52:2454\u201364.", "ArticleIdList": ["19309153"]}, {"Citation": "(a) Yanovsky I, Finkin-Groner E, Zaikin A, et al. . Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer\u2019s disease. J Med Chem 2012;55:10700\u201315.", "ArticleIdList": ["23151013"]}, {"Citation": "(b) Zhang C, Zhou Q, Wu XN, et al. . Discovery of novel PDE9A inhibitors with antioxidant activities for treatment of Alzheimer\u2019s disease. J Enzym Inhib Med Chem 2019;34:260\u201370.", "ArticleIdList": ["PMC7011943", "29271265"]}, {"Citation": "Hassan SZ, Gheita TA, Kenawy SA, et al. . Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity. Int J Rheum Dis 2011;14:325\u201331.", "ArticleIdList": ["22004228"]}, {"Citation": "Segovia J, Perez-Severiano F.. Oxidative damage in Huntington\u2019s disease. Methods Mol Biol 2004;277:321\u201334.", "ArticleIdList": ["15201466"]}, {"Citation": "Secci D, Carradori S, Petzer A, et al. . 4-(3-Nitrophenyl) thiazol-2-ylhydrazone derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysis. J Enzym Inhib Med Chem 2019;34:597\u2013612.", "ArticleIdList": ["PMC6366404", "30727777"]}, {"Citation": "Signorelli SS, Scuto S, Marino E, et al. . Oxidative stress in Peripheral Arterial Disease (PAD) mechanism and biomarkers. Antioxidants 2019;8:367.", "ArticleIdList": ["PMC6770183", "31480714"]}, {"Citation": "Hao X, Qi G, Ma H, et al. . Novel 2-phenoxypyrido [3, 2-b] pyrazin-3 (4\u2009H)-one derivatives as potent and selective aldose reductase inhibitors with antioxidant activity. J Enzym Inhib Med Chem 2019;34:1368\u201372.", "ArticleIdList": ["PMC6711126", "31347930"]}, {"Citation": "Franco R, Schoneveld O, Georgakilas AG, Panayiotidis MI.. Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett 2008;266:6\u201311.", "ArticleIdList": ["18372104"]}, {"Citation": "Kakkar R. Isatin and its derivatives: a survey of recent syntheses, reactions, and applications. MedChemComm 2019;10:351\u201368.", "ArticleIdList": ["PMC6438150", "30996856"]}, {"Citation": "Thanh ND, Giang NTK, Quyen TH, et al. . Synthesis and evaluation of in\u00a0vivo antioxidant, in\u00a0vitro antibacterial, MRSA and antifungal activity of novel substituted isatin N-(2, 3, 4, 6-tetra-O-acetyl-\u03b2-d-glucopyranosyl) thiosemicarbazones. Eur J Med Chem 2016;123:532\u201343.", "ArticleIdList": ["27517802"]}, {"Citation": "Eldehna WM, Al-Wabli RI, Almutairi MS, et al. . Synthesis and biological evaluation of certain hydrazonoindolin-2-one derivatives as new potent anti-proliferative agents. J Enzym Inhib Med Chem 2018;33:867\u201378.", "ArticleIdList": ["PMC7011955", "29707975"]}, {"Citation": "Eldehna WM, El Kerdawy AM, Al-Ansary GH, et al. . Type IIA-Type IIB protein tyrosine kinase inhibitors hybridization as an efficient approach for potent multikinase inhibitor development: Design, synthesis, anti-proliferative activity, multikinase inhibitory activity and molecular modeling of novel indolinone-based ureides and amides. Eur J Med Chem 2019;163:37\u201353.", "ArticleIdList": ["30503942"]}, {"Citation": "Abdel-Aziz HA, Eldehna WM, Keeton AB, et al. . Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in\u00a0vitro pharmacological profiling. Drug Des Dev Ther 2017;11:2333\u201346.", "ArticleIdList": ["PMC5557401", "28848327"]}, {"Citation": "Bindra JS. Oxindole alkaloids. In: Manske RHF, ed. The alkaloids. Vol 14. New York: Academic Press; 1973:84\u2013121."}, {"Citation": "(a) Elderfield RC, Gilman RE.. Alkaloids of Alstonia muelleriana. Phytochemistry 1972;11:339\u201343."}, {"Citation": "(b) Ghedira K, Zeches-Hanrot M, Richard B, et al. . Alkaloids of Alstonia angustifolia. Phytochemistry 1988;27:3955\u201362."}, {"Citation": "Jossang A, Jossang P, Hadi HA, et al. . Horsfiline, an oxindole alkaloid from Horsfieldia superba. J Org Chem 1991;56:6527\u201330."}, {"Citation": "Anderton N, Cockrum PA, Colegate SM, et al. . Oxindoles from Phalaris coerulescens. Phytochemistry 1998;48:437\u20139."}, {"Citation": "Sakai S, Aimi N, Yamaguchi K, et al. . Gardneria alkaloids-IX structures of chitosenine and three other minor bases: from Gardneria multiflora makino. Tetrahedron Lett 1975;16:715\u20138."}, {"Citation": "M Heravi M, Zadsirjan V, Malmir M.. Application of the asymmetric pictet\u2013spengler reaction in the total synthesis of natural products and relevant biologically active compounds. Molecules 2018;23:943.", "ArticleIdList": ["PMC6017108", "29670061"]}, {"Citation": "Cui C-B, Kakeya H, Osada H.. Novel mammalian cell cycle inhibitors, spirotryprostatins A and B, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2/M phase. Tetrahedron 1996;52:12651\u201366."}, {"Citation": "Kaur M, Singh B, Singh B, Arjuna A.. Synthesis and evaluation of novel spiro [oxindole\u2010isoxazolidine] derivatives as potent antioxidants. J Heterocycl Chem 2017;54:1348\u201354."}, {"Citation": "Yu B, Yu D-Q, Liu H-M.. Spirooxindoles: promising scaffolds for anticancer agents. Eur J Med Chem 2015;97:673\u201398.", "ArticleIdList": ["24994707"]}, {"Citation": "Ibrahim HS, Eldehna WM, Fallacara AL, et al. . One-pot synthesis of spiro (indoline-3, 4\u2032-pyrazolo [3, 4-b] pyridine)-5\u2032-carbonitriles as p53-MDM2 interaction inhibitors. Future Med Chem 2018;10:2771\u201389.", "ArticleIdList": ["30526032"]}, {"Citation": "Eldehna WM, El-Naggar DH, Hamed AR, et al. . One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDAMB-231 cells. J Enzym Inhib Med Chem 2018;33:309\u201318.", "ArticleIdList": ["PMC6009943", "29281924"]}, {"Citation": "Denizot F, Lang R.. Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;89:271\u20137.", "ArticleIdList": ["3486233"]}, {"Citation": "Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55\u201363.", "ArticleIdList": ["6606682"]}, {"Citation": "Eldehna WM, Hassan GS, Al-Rashood ST, et al. . Synthesis and in\u00a0vitro anticancer activity of certain novel 1-(2-methyl-6-arylpyridin-3-yl)- 3-phenylureas as apoptosis-inducing agents. J Enzym Inhib Med Chem 2019;34:322\u201332.", "ArticleIdList": ["PMC6366416", "30722708"]}, {"Citation": "El-Naggar M, Eldehna WM, Almahli H, et al. . Novel thiazolidinone/thiazolo[3,2-a] benzimidazolone-isatin conjugates as apoptotic anti-proliferative agents towards breast cancer: one-pot synthesis and in\u00a0vitro biological evaluation. Molecules 2018;23:1420.", "ArticleIdList": ["PMC6099623", "29895744"]}, {"Citation": "Eldehna WM, Abo-Ashour MF, Ibrahim HS, et al. . Novel [(3-indolylmethylene)hydrazono]indolin-2-ones as apoptotic anti-proliferative agents: design, synthesis and in\u00a0vitro biological evaluation. J Enzym Inhib Med Chem 2018;33:686\u2013700.", "ArticleIdList": ["PMC6010103", "29560733"]}, {"Citation": "Sabt A, Abdelhafez OM, El-Haggar RS, et al. . Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, in\u00a0vitro biological evaluation, and QSAR studies. J Enzym Inhib Med Chem 2018;33:1095\u2013107.", "ArticleIdList": ["PMC6022226", "29944015"]}, {"Citation": "Brand-Williams W, Cuvelier ME, Berset C.. Use of a free radical method to evaluate antioxidant activity. LWT-Food Sci Technol 1995;28:25\u201330."}, {"Citation": "Benzie IFF, Strain JJ.. The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: The FRAP assay. Anal Biochem 1996;239:70\u20136.", "ArticleIdList": ["8660627"]}, {"Citation": "Sordon S, Pop\u0142o\u0144ski J, Milczarek M, et al. . Structure\u2013antioxidant\u2013antiproliferative activity relationships of natural C7 and C7\u2013C8 hydroxylated flavones and flavanones. Antioxidants 2019;8:210.", "ArticleIdList": ["PMC6680932", "31284642"]}, {"Citation": "Stana A, Vodnar DC, Marc G, et al. . Antioxidant activity and antibacterial evaluation of new thiazolin-4-one derivatives as potential tryptophanyl-tRNA synthetase inhibitors. J Enzym Inhib Med Chem 2019;34:898\u2013908.", "ArticleIdList": ["PMC6450493", "30938216"]}, {"Citation": "Swiss Institute of Bioinformatics. http://www.swissadme.ch/index.php."}, {"Citation": "Daina A, Zoete V.. A boiled\u2010egg to predict gastrointestinal absorption and brain penetration of small molecules. Chem Med Chem 2016;11:1117\u201321.", "ArticleIdList": ["PMC5089604", "27218427"]}, {"Citation": "Szakacs G, et al. . The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Discov Today 2008;13:379\u201393.", "ArticleIdList": ["18468555"]}, {"Citation": "Daina A, Michielin O, Zoete V.. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017;7:42717.", "ArticleIdList": ["PMC5335600", "28256516"]}, {"Citation": "Daina A, Michielin O, Zoete V.. iLOGP: a simple, robust, and efficient description of n-octanol/water partition coefficient for drug design using the GB/SA approach. J Chem Inf Model 2014;54:3284\u2013301.", "ArticleIdList": ["25382374"]}, {"Citation": "Lipinski CA, Lombardo F, Dominy BW, Feeney PJ.. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3\u201326.", "ArticleIdList": ["11259830"]}, {"Citation": "Veber DF, Johnson SR, Cheng HY, et al. . Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 2002;45:2615\u20132623.", "ArticleIdList": ["12036371"]}, {"Citation": "Egan WJ, Merz KM, Baldwin JJ.. Prediction of drug absorption using multivariate statistics. J Med Chem 2000;43:3867\u201377.", "ArticleIdList": ["11052792"]}, {"Citation": "Ghose AK, Viswanadhan VN, Wendoloski JJ.. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1999;1:55\u201368.", "ArticleIdList": ["10746014"]}, {"Citation": "Cheng T, Zhao Y, Li X, et al. . Computation of octanol\u2009\u2212\u2009water partition coefficients by guiding an additive model with knowledge. J Chem Inf Model 2007;47:2140\u20138.", "ArticleIdList": ["17985865"]}]}], "History": [{"Year": "2020", "Month": "3", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "25"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32208781", "PMC7144320", "10.1080/14756366.2020.1743281"]}}]}